Viewing Study NCT02952092


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-02-24 @ 12:26 AM
Study NCT ID: NCT02952092
Status: COMPLETED
Last Update Posted: 2024-10-30
First Post: 2016-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module